Literature DB >> 29153864

Changes in Markers of Thrombin Generation and Interleukin-6 During Unicondylar Knee and Total Knee Arthroplasty.

Edwin P Su1, Lauren E Mount1, Allina A Nocon2, Thomas P Sculco1, George Go3, Nigel E Sharrock3.   

Abstract

BACKGROUND: Total knee arthroplasty (TKA) is associated with a risk of thromboembolism requiring routine thromboprophylaxis, but there is debate about the risk with unicondylar knee arthroplasty (UKA) as it is a more minor procedure. We sought to investigate the relative risk of thromboembolism with UKA compared to TKA and one-staged bilateral TKA (BTKA) by measuring the increase in circulating biochemical markers of thrombin generation during the procedures. Degree of surgical trauma was also assessed by measuring interleukin-6, a marker of metabolic injury.
METHODS: We prospectively studied a total of 75 patients: 25 patients undergoing UKA, unilateral TKA, and BTKA, respectively. All patients had surgery performed with tourniquet and received no tranexamic acid. Blood samples were taken during surgery and assayed for circulating markers of thrombin generation: prothrombin fragment 1+2 (F1+2) and thrombin-antithrombin complexes plus interleukin-6.
RESULTS: Thrombin-antithrombin complexes, increased during all time points (P < .001) but was not significantly different between surgical treatment groups. F1+2 also rose significantly during surgery, with no significant difference between UKA and TKA. There was, however, a significant difference in F1+2 between BTKA and UKA or TKA (P < .02). Interleukin-6 rose minimally with UKA but rose significantly with TKA and BTKA (P < .001).
CONCLUSION: Based on these data of circulating biochemical markers, patients undergoing UKA are at similar risk of thromboembolism with respect to TKA despite a lower index of metabolic injury. We believe that UKA patients should receive thromboprophylaxis comparable to TKA patients.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  coagulation; deep vein thrombosis; metabolic injury; risk; total knee arthroplasty; unicompartmental knee arthroplasty

Mesh:

Substances:

Year:  2017        PMID: 29153864      PMCID: PMC6545237          DOI: 10.1016/j.arth.2017.10.016

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  4 in total

1.  An alternative method for personalized tourniquet pressure in total knee arthroplasty: a prospective randomized and controlled study.

Authors:  Jun Wu; QiWei Fu; HaoBo Li; YaGuang Han; JianHua Deng; Yi Chen; QiRong Qian
Journal:  Sci Rep       Date:  2022-06-10       Impact factor: 4.996

2.  Plasminogen activator inhibitor-1, thrombin-antithrombin, and prothrombin fragment F1+2 have higher diagnostic values than D-dimer for venous thromboembolism after TKA.

Authors:  Yong Yang; Gangning Feng; Jiangbo Yan; Long Wu; Faxuan Wang; Dong Ding; Hui Wang; Qunhua Jin
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

3.  Prospective, randomised, controlled study on the efficacy and safety of different strategies of tranexamic acid with total blood loss, blood transfusion rate and thrombogenic biomarkers in total knee arthroplasty: study protocol.

Authors:  Yong Yang; Zheng Wang; Faxuan Wang; Xin Zhao; Kaijie Yang; Jinlong He; Yun Jin; Haibo Yang; Dong Ding; Qunhua Jin
Journal:  BMJ Open       Date:  2021-02-26       Impact factor: 2.692

4.  Effect of remote ischemic preconditioning on fibrin formation and metabolism in patients undergoing hip fracture surgery: a randomized clinical trial.

Authors:  Kirsten L Wahlstrøm; Sarah Ekeloef; Johannes J Sidelmann; Ismail Gögenur; Anna-Marie B Münster
Journal:  Blood Coagul Fibrinolysis       Date:  2022-01-01       Impact factor: 1.061

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.